Featured Article While neuromodulators are exceptionally safe for cosmetic use, complications such as neutralizing antibody formation and eyelid ptosis can occasionally occur. Experts participating in the “Thriving in Diversity” webinar…
Glabellar Contraction Patterns in Black Patients: Implications for Botulinum Toxin Treatment Botulinum toxin is widely used for treating dynamic glabellar lines, but contraction patterns in Black patients had not been…
Comparing Biostimulatory Agents for Skin Rejuvenation Injectable biostimulators like poly-L-lactic acid (PLLA-SCA™) and calcium hydroxylapatite (CaHA-R) are used to stimulate collagen production in aging skin, but their molecular effects differ.…
Featured Article Exosomes are emerging as a cutting-edge innovation in cosmetic dermatology, showing potential in skin rejuvenation, hair restoration, and pigmentation correction. But how close are we to seeing them…
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis Check our all-new video abstract from Christopher G. Bunick MD PhD, who gives structural insights into what makes some…
JDD Article Highlight Rosacea’s hallmark redness stems from persistent changes in the skin’s blood vessels. But treatment options targeting these vessels are advancing. Alpha-agonists like oxymetazoline and brimonidine reduce redness, while…
Featured Podcast Don't pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind. The world of acne treatment R&D is unfortunately shrinking as payors pick away…
JDD: 2024 Trending Topics in Dermatology - Part 2 Dear Readers, As we close another year of groundbreaking dermatologic advancements, I am delighted to share a curated selection of articles…
JDD: 2024 Trending Topics in Dermatology - Part 1 Dear Readers, As we close another year of groundbreaking dermatologic advancements, I am delighted to share a curated selection of articles…
JDD Article Highlight Treating acne isn’t just about prescriptions—it’s about pairing the right skincare routine with medical therapy. This JDD article highlights how combining pharmacological treatments with a personalized dermocosmetic regimen…
JDD Article Highlight Melasma affects people worldwide, particularly women and individuals with darker skin tones. But how well do clinical trials reflect this diversity? This JDD article analyzed 19 melasma trials…
JDD Article Highlight Could targeting the JAK/STAT pathway redefine how we approach cutaneous lupus erythematosus (CLE)? Spanning acute (ACLE), subacute (SCLE), and chronic (CCLE) forms, CLE presents a spectrum of…